Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 142.87% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.05M.
Fairly Valued
The company’s latest PE is -0.19, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.95K shares, decreasing 98.98% quarter-over-quarter.